John Gregory Cairncross
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Genetics 144
- Glioma Diagnosis and Treatment 144
-
- Cancer, Hypoxia, and Metabolism 12
- MicroRNA in disease regulation 11
- Co-authors
- Roger Stupp (7 shared papers)Warren P. Mason (9 shared papers)Michael Weller (6 shared papers)R.O. Mirimanoff (5 shared papers)Thierry Gorlia (5 shared papers)Robert Charles Janzer (2 shared papers)Martin J. van den Bent (9 shared papers)David R. Macdonald (25 shared papers)
- Journals
- Neuro-Oncology (23 papers)Journal of Neuro-Oncology (16 papers)Journal of Clinical Oncology (14 papers)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (13 papers)International Journal of Radiation Oncology*Biology*Physics (12 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
John Gregory Cairncross
196 papers receiving 47.6k citations
John Gregory Cairncross's Hit Papers
Peers
Comparison fields: 5 of 175
- Genetics 30.0k
- Cancer Research 8.8k
- Pulmonary and Respiratory Medicine 8.4k
- Neurology 3.7k
- Oncology 6.1k
Countries citing papers authored by John Gregory Cairncross
This map shows the geographic impact of John Gregory Cairncross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gregory Cairncross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gregory Cairncross more than expected).
Fields of papers citing papers by John Gregory Cairncross
This network shows the impact of papers produced by John Gregory Cairncross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gregory Cairncross. The network helps show where John Gregory Cairncross may publish in the future.
Co-authors
The 25 scholars most cited alongside John Gregory Cairncross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma Hit paper breakdown → | 2005 | 17738 |
| 2 | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Hit paper breakdown → | 2009 | 6545 |
| 3 | MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma Hit paper breakdown → | 2005 | 5960 |
| 4 | Response criteria for phase II studies of supratentorial malignant glioma. Hit paper breakdown → | 1990 | 2127 |
| 5 | Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas Hit paper breakdown → | 1998 | 1326 |
| 6 | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma Hit paper breakdown → | 2017 | 869 |
| 7 | Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Hit paper breakdown → | 2003 | 788 |
| 8 | Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma Hit paper breakdown → | 2008 | 604 |
| 9 | 2007 | 452 | |
| 10 | Radation therapy for brain metastases Hit paper breakdown → | 1980 | 394 |
| 11 | Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. | 2001 | 374 |
| 12 | 2014 | 342 | |
| 13 | 2006 | 317 | |
| 14 | 2009 | 314 | |
| 15 | 1982 | 305 | |
| 16 | 1988 | 301 | |
| 17 | cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant Hit paper breakdown → | 2018 | 296 |
| 18 | 1989 | 266 | |
| 19 | 1992 | 249 | |
| 20 | 2011 | 248 |
About John Gregory Cairncross
John Gregory Cairncross is a scholar working on Genetics, Cancer Research, Pulmonary and Respiratory Medicine, Neurology and Oncology, having authored 199 papers that have together received 48.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (144 papers), Brain Metastases and Treatment (39 papers), Neuroblastoma Research and Treatments (17 papers), Meningioma and schwannoma management (15 papers), Cancer, Hypoxia, and Metabolism (12 papers), MicroRNA in disease regulation (11 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Epigenetics and DNA Methylation (10 papers). The work is most often cited by research in Genetics (30.0k citations), Cancer Research (8.8k citations), Pulmonary and Respiratory Medicine (8.4k citations), Neurology (3.7k citations) and Oncology (6.1k citations). John Gregory Cairncross has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Roger Stupp, Warren P. Mason, Michael Weller, R.O. Mirimanoff, Thierry Gorlia, Robert Charles Janzer, Martin J. van den Bent, David R. Macdonald, Alba Ariela Brandes and Denis Lacombe. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.